News

Company’s flagship medical device, CoRISMA, is designed to dramatically improve outcomes for millions with heart failure Bonde Innovations, LLC, a venture-backed developer of a medical device intended to improve outcomes for patients with...

Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are testing a new lifestyle intervention program and digital health platform for patients with atrial fibrillation (AFib), the most common type of...

FDA 510(k) cleared Beat Detection analytic allows physIQ to power its higher-level AI analytics with validated vital sign inputs This clearance would not be possible if not for physIQ’s unprecedented 1.5 million+ hours of continuous...

Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart failure with...

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot Line session at ESC Congress 2020.1 Rhythm control therapy is typically delayed...

Medtronic plc, the global leader in medical technology, announced clinical trial results demonstrating superiority of the Arctic Front™ Advance Cardiac Cryoballoon and Freezor® MAX Cardiac CryoAblation Catheter for the first-line treatment...

Daiichi Sankyo Europe announced one-year results of four sub-analyses from the European and global ETNA-AF (Edoxaban Treatment in routiNe clinical prActice in patients with nonvalvular Atrial Fibrillation) program, a non-interventional safety...

MyoKardia, Inc. announced that 30-week results from its pivotal Phase 3 EXPLORER-HCM clinical trial of mavacamten for the treatment of symptomatic, obstructive hypertrophic cardiomyopathy (HCM) were presented during a live Hot Line session at...

EMPEROR-Reduced trial presented in a Hot Line Session at ESC Congress 2020 Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction. That’s...

ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Atrial fibrillation is the most common heart rhythm disorder and increases...